Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study

被引：162

作者：

Wood E. ^{[1
,2
]}

Stoltz J.-A. ^{[1
]}

Montaner J.S.G. ^{[1
,2
]}

Kerr T. ^{[1
,2
]}

机构：

[1] British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC V6Z 1Y6

[2] Department of Medicine, University of British Columbia, Vancouver, BC V5Z 4E3

来源：

Harm Reduction Journal | / 3卷 / 1期

关键词：

Human Immunodeficiency Virus; Methamphetamine; Injection Drug; Injection Drug User; Injection Drug User;

D O I：

10.1186/1477-7517-3-18

中图分类号：

学科分类号：

摘要：

Many Canadian cities are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDU). These health concerns have recently been exacerbated by the increasing availability and use of methamphetamine. The challenges of reducing health-related harms among IDU have led to an increased recognition that strategies to prevent initiation into injection drug use must receive renewed focus. In an effort to better explore the factors that may protect against or facilitate entry into injection drug use, the At Risk Youth Study (ARYS) has recently been initiated in Vancouver, Canada. The local setting is unique due to the significant infrastructure that has been put in place to reduce HIV transmission among active IDU. The ARYS study will seek to examine the impact of these programs, if any, on non-injection drug users. In addition, Vancouver has been the site of widespread use of methamphetamine in general and has seen a substantial increase in the use of crystal methamphetamine among street youth. Hence, the ARYS cohort is well positioned to examine the harms associated with methamphetamine use, including its potential role in facilitating initiation into injection drug use. This paper provides some background on the epidemiology of illicit drug use among street youth in North America and outlines the methodology of ARYS, a prospective cohort study of street youth in Vancouver, Canada. © 2006 Wood et al; licensee BioMed Central Ltd.

引用

共 47 条

[1]

National Household Survey on Drug Abuse, The NHSDA Report, (2003)

[2]

Reducing the harm associated with injection drug use in Canada, (2001)

[3]

Tyndall M.W., Craib K.J., Currie S., Li K., O'Shaughnessy M.V., Schechter M.T., Impact of HIV infection on mortality in a cohort of injection drug users, J Acquir Immune Defic Syndr, 28, pp. 351-357, (2001)

[4]

Coffin P.O., Galea S., Ahern J., Leon A.C., Vlahov D., Tardiff K., Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98, Addiction, 98, pp. 739-747, (2003)

[5]

Garfield J., Drucker E., Fatal overdose trends in major US cities: 1990-1997, Addictions Research and Theory, 9, pp. 425-436, (2001)

[6]

Wood E., Tyndall M.W., Spittal P., Li K., Kerr T., Hogg R.S., Montaner J.S.G., O'Shaughnessy M.V., Schechter M.T., Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?, CMAJ, 165, pp. 405-410, (2001)

[7]

Palepu A., Strathdee S.A., Hogg R.S., Anis A.H., Rae S., Cornelisse P.G.A., Patrick D.M., O'Shaughnessy M.V., Schechter M.T., The social determinants of emergency department and hospital use by injection drug users in Canada, J Urban Health, 76, pp. 409-418, (1999)

[8]

Palepu A., Tyndall M.W., Leon H., Muller J., O'Shaughnessy M.V., Schechter M.T., Anis A.H., Hospital utilization and costs in a cohort of injection drug users, CMAJ, 165, pp. 415-420, (2001)

[9]

Wall R., Rehm J., Fischer B., Brands B., Gliksman L., Stewart J., Medved W., Blake J., Social costs of untreated opioid dependence, J Urban Health, 77, pp. 688-722, (2000)

[10]

Wood E., Kerr T., Spittal P.M., Tyndall M.W., O'Shaughnessy M.V., Schechter M.T., The healthcare and fiscal costs of the illicit drug use epidemic: The impact of conventional drug control strategies and the impact of a comprehensive approach, BCMJ, 45, pp. 130-136, (2003)

← 1 2 3 4 5 →